(Q35030176)

5 August 2017

1 reference

title

Natural product derived receptor tyrosine kinase inhibitors: identification of IGF1R, Tie-2, and VEGFR-3 inhibitors (English)

1 reference

5 August 2017

1 reference

3

Ralph Mazitschek

0 references

Herbert Waldmann

5

object named as

Herbert Waldmann

1 reference

5 August 2017

Petra Stahl

1

1 reference

5 August 2017

Lars Kissau

2

1 reference

5 August 2017

Ralph Mazitschek

3

1 reference

5 August 2017

Athanassios Giannis

4

1 reference

5 August 2017

1 April 2002

1 reference

5 August 2017

1 reference

5 August 2017

41

1 reference

5 August 2017

7

1 reference

5 August 2017

1174-1178

1 reference

Angiogenesis in cancer, vascular, rheumatoid and other disease

5 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Vascular-specific growth factors and blood vessel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Differential inhibition of tumor angiogenesis by tie2 and vascular endothelial growth factor receptor-2 dominant-negative receptor mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Natural products are biologically validated starting points in structural space for compound library development: solid-phase synthesis of dysidiolide-derived phosphatase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Total synthesis and biological evaluation of the nakijiquinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Insulin-like growth factors in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

CHARMM: A program for macromolecular energy, minimization, and dynamics calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Comparative protein modelling by satisfaction of spatial restraints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

WHAT IF: a molecular modeling and drug design program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Errors in protein structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Comparative protein structure modeling of genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

DIALIGN 2: improvement of the segment-to-segment approach to multiple sequence alignment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1521-3773%2820020402%2941%3A7%3C1174%3A%3AAID-ANIE1174%3E3.0.CO%3B2-V

10.1002/1521-3773(20020402)41:7<1174::AID-ANIE1174>3.0.CO;2-V

21 January 2018

Identifiers

DOI

1 reference

release_nxbfqun2tjfctdqlgmrjnhutfq

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nxbfqun2tjfctdqlgmrjnhutfq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference